Organogenesis Holdings Inc.
ORGO
$2.48
$0.104.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 512.59M | 563.03M | 464.62M | 429.31M | 458.76M |
| Total Other Revenue | 2.12M | 1.14M | 603.00K | 226.00K | -- |
| Total Revenue | 514.70M | 564.17M | 465.22M | 429.53M | 458.76M |
| Cost of Revenue | 134.39M | 132.34M | 118.66M | 109.20M | 110.77M |
| Gross Profit | 380.31M | 431.83M | 346.56M | 320.33M | 347.99M |
| SG&A Expenses | 314.54M | 325.72M | 299.40M | 291.97M | 294.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 497.99M | 502.60M | 463.84M | 444.08M | 453.57M |
| Operating Income | 16.71M | 61.57M | 1.38M | -14.55M | 5.19M |
| Income Before Tax | 4.28M | 46.97M | -6.20M | -21.54M | -24.25M |
| Income Tax Expenses | 1.56M | 9.94M | -7.21M | -13.31M | -8.37M |
| Earnings from Continuing Operations | 2.72 | 37.03 | 1.01 | -8.23 | -15.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.72M | 37.03M | 1.01M | -8.23M | -15.88M |
| EBIT | 16.71M | 61.57M | 1.38M | -14.55M | 5.19M |
| EBITDA | 40.90M | 80.16M | 19.56M | 3.17M | 22.53M |
| EPS Basic | -0.11 | 0.16 | -0.07 | -0.10 | -0.16 |
| Normalized Basic EPS | 0.09 | 0.31 | 0.02 | -0.07 | 0.02 |
| EPS Diluted | -0.13 | 0.14 | -0.08 | -0.10 | -0.17 |
| Normalized Diluted EPS | 0.08 | 0.30 | 0.01 | -0.07 | 0.02 |
| Average Basic Shares Outstanding | 508.45M | 506.95M | 509.72M | 515.41M | 521.12M |
| Average Diluted Shares Outstanding | 517.71M | 516.21M | 516.17M | 519.24M | 524.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |